First-Line XELOX Plus Bevacizumab Followed by XELOX Plus Bevacizumab or Single-Agent Bevacizumab as Maintenance Therapy in Patients with Metastatic Colorectal Cancer: The Phase III MACRO TTD Study
Eduardo Díaz‐Rubio(Hospital Clínico San Carlos), Amelia López-Ladrón(Hospital Universitario de Valme), A. Arriví(Hospital Son Llatzer), Bartomeu Massutí(Universitat de Miguel Hernández d'Elx), Josep Tabernero(Deaconess Hospital), María José Safont(Hospital General Universitario De Valencia), Marta Llanos(Hospital Universitario de Canarias), P. Escudero(Hospital Clínico Universitario Lozano Blesa), Ferrán Losa, Albert Abad, Carlos Fernández-Martos(Fundación Instituto Valenciano de Oncología), Encarnación González‐Flores(Hospital Universitario Virgen de las Nieves), Manuel Benavides(Hospital Clínico Universitario Virgen de la Victoria), Enrique Aranda(Instituto Maimónides de Investigación Biomédica de Córdoba), Manuel Gallén(Hospital Del Mar), Javier Sastre(Hospital Clínico San Carlos), Rosario Dueñas(Complejo Hospitalario de Jaén), Fernando Rivera(Marqués de Valdecilla University Hospital), Antonio Antón(Hospital Universitario Miguel Servet), Andrés Cervantes(INCLIVA Health Research Institute), Eugenio Marcuello(Hospital de Sant Pau), Purificación Martínez de Prado(Hospital de Basurto), Auxiliadora Gómez‐España(Hospital Universitario Reina Sofía), Manuel Valladares(American Society of Clinical Oncology)
Cited by 213
Related Papers
Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
|New England Journal of Medicine|2013|6.6k
Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial
|The Lancet Oncology|2012|5.5k
The consensus molecular subtypes of colorectal cancer
|Nature Medicine|2015|5.3k
The landscape of somatic copy-number alteration across human cancers
|Nature|2010|4.1k
Leucovorin and Fluorouracil With or Without Oxaliplatin as First-Line Treatment in Advanced Colorectal Cancer
|Journal of Clinical Oncology|2000|3.8k